137 related articles for article (PubMed ID: 6419288)
21. Characterization of lipoxygenase metabolites of arachidonic acid in cultured human skin fibroblasts.
Mayer B; Rauter L; Zenzmaier E; Gleispach H; Esterbauer H
Biochim Biophys Acta; 1984 Aug; 795(1):151-61. PubMed ID: 6432053
[TBL] [Abstract][Full Text] [Related]
22. Distribution of monohydroxy fatty acids in specific human epidermal phospholipids.
Grøn B; Iversen L; Ziboh V; Kragballe K
Exp Dermatol; 1993 Feb; 2(1):38-44. PubMed ID: 8156169
[TBL] [Abstract][Full Text] [Related]
23. Modulation of eicosanoid formation by lesional skin of psoriasis: an ex vivo skin model.
Fogh K; Iversen L; Herlin T; Kragballe K
Acta Derm Venereol; 1993 Jun; 73(3):191-3. PubMed ID: 8105616
[TBL] [Abstract][Full Text] [Related]
24. NADPH-dependent formation of 15- and 12-hydroxyeicosatrienoic acid from arachidonic acid by rat epidermal microsomes.
Van Wauwe J; Coene MC; Van Nyen G; Cools W; Goossens J; Le Jeune L; Lauwers W; Janssen PA
Eicosanoids; 1991; 4(3):155-63. PubMed ID: 1772688
[TBL] [Abstract][Full Text] [Related]
25. Response of psoriatic lesions to multiple applications of leukotriene B4 and 12-HETE.
Norris PG; Schofield O; Dowd PM; Greaves MW
Dermatologica; 1987; 174(5):219-23. PubMed ID: 3034690
[TBL] [Abstract][Full Text] [Related]
26. Generation of the arachidonic acid metabolite 8-HETE by extracts of mouse skin treated with phorbol ester in vivo; identification by 1H-n.m.r. and GC-MS spectroscopy.
Gschwendt M; Fürstenberger G; Kittstein W; Besemfelder E; Hull WE; Hagedorn H; Opferkuch HJ; Marks F
Carcinogenesis; 1986 Mar; 7(3):449-55. PubMed ID: 3081276
[TBL] [Abstract][Full Text] [Related]
27. Analysis of cytochrome P450 metabolites of arachidonic and linoleic acids by liquid chromatography-mass spectrometry with ion trap MS.
Bylund J; Ericsson J; Oliw EH
Anal Biochem; 1998 Dec; 265(1):55-68. PubMed ID: 9866708
[TBL] [Abstract][Full Text] [Related]
28. Biosynthesis of 12(S)-hydroxyeicosatetraenoic acid by B16 amelanotic melanoma cells is a determinant of their metastatic potential.
Liu B; Marnett LJ; Chaudhary A; Ji C; Blair IA; Johnson CR; Diglio CA; Honn KV
Lab Invest; 1994 Mar; 70(3):314-23. PubMed ID: 8145526
[TBL] [Abstract][Full Text] [Related]
29. Metabolism of 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid and other hydroxylated fatty acids by the reductase pathway in porcine polymorphonuclear leukocytes.
Wainwright S; Falck JR; Yadagiri P; Powell WS
Biochemistry; 1990 Oct; 29(43):10126-35. PubMed ID: 2176862
[TBL] [Abstract][Full Text] [Related]
30. Hepoxilin B3 and its enzymatically formed derivative trioxilin B3 are incorporated into phospholipids in psoriatic lesions.
Antón R; Camacho M; Puig L; Vila L
J Invest Dermatol; 2002 Jan; 118(1):139-46. PubMed ID: 11851887
[TBL] [Abstract][Full Text] [Related]
31. Leukotrienes C4 and D4 in psoriatic skin lesions.
Brain SD; Camp RD; Black AK; Dowd PM; Greaves MW; Ford-Hutchinson AW; Charleson S
Prostaglandins; 1985 Apr; 29(4):611-9. PubMed ID: 2988023
[TBL] [Abstract][Full Text] [Related]
32. Cutaneous responses to 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE).
Dowd PM; Kobza Black A; Woollard PM; Camp RD; Greaves MW
J Invest Dermatol; 1985 Jun; 84(6):537-41. PubMed ID: 3998504
[TBL] [Abstract][Full Text] [Related]
33. Increased activity and stimulability of psoriatic epidermal soluble guanylate cyclase by arachidonic acid and 12-hydroxy-5,8,10,14-eicosatetraenoic acid.
Cantieri JS; Graff G; Goldberg ND
Adv Cyclic Nucleotide Res; 1980; 12():139-46. PubMed ID: 6105812
[TBL] [Abstract][Full Text] [Related]
34. An enzymatic method for distinguishing the stereoisomers of 12-hydroxyeicosatetraenoic acid in human epidermis and psoriatic scale.
Opas EE; Argenbright LW; Humes JL
Br J Dermatol; 1989 Jan; 120(1):49-58. PubMed ID: 2517876
[TBL] [Abstract][Full Text] [Related]
35. Lipoxygenase products of arachidonic acid in human inflamed skin.
Black AK; Barr RM; Wong E; Brain S; Greaves MW; Dickinson R; Shroot B; Hensby CN
Br J Clin Pharmacol; 1985 Sep; 20(3):185-90. PubMed ID: 2994700
[TBL] [Abstract][Full Text] [Related]
36. The analysis of arachidonic acid metabolites in normal, uninvolved and lesional psoriatic skin.
Barr RM; Wong E; Mallet AI; Olins LA; Greaves MW
Prostaglandins; 1984 Jul; 28(1):57-65. PubMed ID: 6435188
[TBL] [Abstract][Full Text] [Related]
37. Topical steroid treatment reduces arachidonic acid and leukotriene B4 in lesional skin of psoriasis.
Wong E; Barr RM; Cunningham FM; Mistry K; Woollard PM; Mallet AI; Greaves MW
Br J Clin Pharmacol; 1986 Dec; 22(6):627-32. PubMed ID: 3032226
[TBL] [Abstract][Full Text] [Related]
38. Cyclic GMP metabolism in psoriasis: activation of soluble epidermal guanylate cyclase by arachidonic acid and 12-hydroxy-5,8,10,14-eicosatetraenoic acid.
Cantieri JS; Graff G; Goldberg ND
J Invest Dermatol; 1980 Apr; 74(4):234-7. PubMed ID: 6103015
[TBL] [Abstract][Full Text] [Related]
39. Conversion of linoleic acid and arachidonic acid by skin epidermal lipoxygenases.
Nugteren DH; Kivits GA
Biochim Biophys Acta; 1987 Sep; 921(1):135-41. PubMed ID: 3113487
[TBL] [Abstract][Full Text] [Related]
40. 16(R)-hydroxy-5,8,11,14-eicosatetraenoic acid, a new arachidonate metabolite in human polymorphonuclear leukocytes.
Bednar MM; Gross CE; Balazy MK; Belosludtsev Y; Colella DT; Falck JR; Balazy M
Biochem Pharmacol; 2000 Aug; 60(3):447-55. PubMed ID: 10856441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
